FDA publishes guidance on Competitive Generic Therapies

19-02-2019

FDA publishes guidance on Competitive Generic Therapies

ca-ssis / iStockphoto.com

The US Food and Drug Administration (FDA) has published new draft guidance on a pathway intended to boost the development of generics and lower drug prices.


US Food and Drug Administration, competitive generic therapies, market exclusivity, abbreviated new drug application, Scott Gottlieb

LSIPR